Boehringer’s Pradaxa Wins UK Agency’s Backing in Stroke

Boehringer Ingelheim’s Pradaxa blood-thinner won the recommendation of the UK’s medical-cost regulator to prevent strokes in people with a type of irregular heartbeat.
Bloomberg